[The metabolic syndrome in the daily clinic].
An obesity epidemic has spread all over the world during the past 30-40 years. Persons becoming viscerally obese have a large risk of developing dysmetabolism characterised by ectopic fat accumulation resulting in increased triglyceride content and reduced HDL-cholesterol in the blood, arterial hypertension and type 2 diabetes. Today, this phenotype is designated metabolic syndrome (MS). The International Diabetes Federation (IDF) has presented an operational definition making it possible to intervene against the basal components of the syndrome early in the course of the syndrome in order to reduce its serious consequences in terms of increased morbidity and mortality.